Sven Lange joined Vivostat A/S in 2010 and has served as CEO since 2014

His responsibilities, besides managing the company, include identifying new applications for the Vivostat® system, and exploring opportunities for growth. He is further responsible for clinical and regulatory matters.

Past experience includes auditing (Deloitte) and fast moving consumer goods (Coop) but for the last 20 years the focus has been devoted to the medical device industry. The most recent positions include heading 2 start-up companies (Pharma 2100 and NMD Care) and a Senior Vice President role at Coloplast A/S.

A close connection to the start-up environment is maintained through active board memberships in medtech start-ups.

Sven has a Master's degree in Economics and Business Administration from Copenhagen Business School (CBS).